Clinical Research in Cardiology

, Volume 103, Issue 8, pp 591–597

Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2014

  • Dirk Westermann
  • Reinhold Kreutz
  • Claudius Jacobshagen
Clinical Trial Updates and Hotline Sessions

Abstract

This article provides information and commentaries on trials which were presented at the Hotline and Clinical Trial Update Sessions during the Late Breaking Clinical Trial Sessions at the 63rd annual meeting of the American College of Cardiology in Washington, USA, from 29th to 31st March 2014. This article gives an overview on a number of novel clinical trials in the field of cardiovascular medicine, which were presented. Comprehensive summaries have been generated from the oral presentation and the webcasts of the American College of Cardiology, similar to as previously reported and should provide the readers with the most comprehensive information of relevant publications. The discussed studies are US CoreValve, Choice, Symplcity-HTN-3, GRS, ZEUS, GIPS-III, HEAT-PPCI, COPR-2, MSC-HF, POISE-2, SIRS. The data were presented by leading experts in the field.

Keywords

US CoreValve Symplcity-HTN-3 GIPS-III COPR-2 POISE-2 

References

  1. 1.
    Leon MB et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607PubMedCrossRefGoogle Scholar
  2. 2.
    Smith CR et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198PubMedCrossRefGoogle Scholar
  3. 3.
    Adams DH et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798PubMedCrossRefGoogle Scholar
  4. 4.
    Haussig S, Schuler G, Linke A (2014) Worldwide TAVI registries: what have we learned? Clin Res Cardiol. doi:10.1007/s00392-014-0698-y
  5. 5.
    Sherif MA et al (2014) Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol. doi:10.1007/s00392-014-0690-6
  6. 6.
    Akin I et al (2012) Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation. Clin Res Cardiol Off J Ger Card Soc 101:357–364CrossRefGoogle Scholar
  7. 7.
    Chorianopoulos E, Krumsdorf U, Pleger ST, Katus HA, Bekeredjian R (2012) Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve((R)) aortic bioprosthesis. Clin Res Cardiol Off J Ger Card Soc 101:349–355CrossRefGoogle Scholar
  8. 8.
    Abdel-Wahab M et al (2014) Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA J Am Med Assoc 311:1503–1514CrossRefGoogle Scholar
  9. 9.
    Geis NA et al (2014) Feasibility of sheathless transfemoral aortic valve implantation in patients with small access vessel diameters. Clin Res Cardiol. doi:10.1007/s00392-014-0713-3
  10. 10.
    Diemert P et al (2014) Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol Off J Ger Card Soc 103:183–190CrossRefGoogle Scholar
  11. 11.
    Dimitriadis Z et al (2013) Sleep-disordered breathing in patients undergoing transfemoral aortic valve implantation for severe aortic stenosis. Clin Res Cardiol Off J Ger Card Soc 102:895–903CrossRefGoogle Scholar
  12. 12.
    Muensterer A et al (2013) Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access. Clin Res Cardiol Off J Ger Card Soc 102:627–636CrossRefGoogle Scholar
  13. 13.
    Zahn R et al (2013) Occlusion of the left main stem: a rare, but life-threatening complication of transcatheter aortic valve implantation with the Medtronic CoreValve prosthesis. Clin Res Cardiol Off J Ger Card Soc 102:323–326CrossRefGoogle Scholar
  14. 14.
    Beller CJ et al (2013) The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation? Clin Res Cardiol Off J Ger Card Soc 102:111–117CrossRefGoogle Scholar
  15. 15.
    Abdel-Wahab M et al (2012) Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry. Clin Res Cardiol Off J Ger Card Soc 101:973–981CrossRefGoogle Scholar
  16. 16.
    Baath C, Idvall E, Gunningberg L, Hommel A (2014) Pressure-reducing interventions among persons with pressure ulcers: results from the first three national pressure ulcer prevalence surveys in Sweden. J Eval Clin Pract 20:58–65PubMedCrossRefGoogle Scholar
  17. 17.
    Vollmann D, Sossalla S, Schroeter MR, Zabel M (2013) Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation. Clin Res Cardiol Off J Ger Card Soc 102:315–318CrossRefGoogle Scholar
  18. 18.
    Vogel B et al (2014) Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol Off J Ger Card Soc 103:117–124CrossRefGoogle Scholar
  19. 19.
    Seiffert M et al (2014) Development of a risk score for outcome after transcatheter aortic valve implantation. Clin Res Cardiol. doi:10.1007/s00392-014-0692-4
  20. 20.
    Mueller M et al (2012) Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol Off J Ger Card Soc 101:837–845CrossRefGoogle Scholar
  21. 21.
    Bandstein N, Ljung R, Johansson M, Holzmann MJ (2014) Undetectable high sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol. doi:10.1016/j.jacc.2014.03.017
  22. 22.
    Stone GW et al (2008) Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358:2218–2230PubMedCrossRefGoogle Scholar
  23. 23.
    Lexis CP et al (2014) Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA J Am Med Assoc 311:1526–1535CrossRefGoogle Scholar
  24. 24.
    Imazio M et al (2014) Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. doi:10.1016/S0140-6736(13)62709-9
  25. 25.
    Goldenberg I et al (2014) Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med 370(18):1694–1701. doi:10.1056/NEJMoa1401426 PubMedCrossRefGoogle Scholar
  26. 26.
    Wasmer K et al (2013) Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry. Clin Res Cardiol Off J Ger Card Soc 102:513–521CrossRefGoogle Scholar
  27. 27.
    Devereaux PJ et al (2014) Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370:1494–1503PubMedCrossRefGoogle Scholar
  28. 28.
    Devereaux PJ et al (2014) Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370:1504–1513PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Dirk Westermann
    • 1
  • Reinhold Kreutz
    • 2
  • Claudius Jacobshagen
    • 3
  1. 1.Department of General and Interventional CardiologyUniversity Heart Center Hamburg EppendorfHamburgGermany
  2. 2.Department of Clinical Pharmacology and ToxicologyCharité-Universitätsmedizin BerlinBerlinGermany
  3. 3.Clinic for Cardiology and PneumologyGeorg-August-UniversityGöttingenGermany

Personalised recommendations